Howard A. Fine, MD, Neuro-oncologist, Joins NYU Cancer Institute
Howard A. Fine, MD, a renowned neuro-oncologist, has joined the staff of the NYU Cancer Institute. He was appointed the Anne Murnick Cogan and David H. Cogan Professor of Oncology, Chief of the Division of Hematology and Medical Oncology, Director of the Brain Tumor Center, and Deputy Director of the NYUCI.
Prior to his arrival at the NYUCI, Dr. Fine was Chief of the Neuro-Oncology Branch at the National Cancer Institute (NCI), and he held a joint appointment with the National Institute of Neurological Disorders and Stroke as an adjunct investigator. While at the NCI, he developed one of the preeminent brain tumor programs in the world. At the NYUCI, he has a wide range of responsibilities, including directing clinical programs in solid tumor oncology, developmental therapeutics, malignant hematology, and experimental hematology.
“We are delighted to welcome Dr. Fine to the NYU Langone Medical Center faculty,” said William L. Carroll, MD, NYUCI Director. “As one of today’s leading neuro-oncologists and a visionary leader, he brings a wealth of expertise and experience in research to treat brain tumors in adults and children. He will continue to build on the world-class care our patients have already come to expect.”
Dr. Fine completed both his internship and his residency in internal medicine at the Hospital of The University of Pennsylvania. He later completed a fellowship in medical oncology at the Dana-Farber Cancer Institute in Boston.